Navigation Links
Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Date:10/29/2012

SAN FRANCISCO, Oct. 29, 2012 /PRNewswire/ -- Principia Biopharma, Inc., a privately-held biopharmaceutical company focused on advancing best-in-class medicines in immunology, autoimmune diseases, and oncology announced that it successfully met its milestone obligations and received its second tranche of funding totaling $12.5 million in July 2012. The investment was led by existing investors New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.  In February 2011, Principia completed a tiered Series A round of financing totaling $36.3 million and received the first tranche of $12 million that same month.  Proceeds from this most recent financing will be used to advance Principia's lead molecule towards the clinic and to develop additional programs enabled by the company's reversible covalent platform.

(Logo: http://photos.prnewswire.com/prnh/20121029/NY01747LOGO)

Martin Babler, CEO of Principia, says, "We are pleased to complete the closing of our second tranche as it provides the necessary funding for Principia to advance our lead compound toward our first clinical trials in 2013. We appreciate the continued support from our current investors as we invest in important treatments for cancer and autoimmune disorders."

EXPANSION OF SENIOR MANAGEMENT TEAM

As part of Principia's growth and its initiatives to bring new medicines to patients, the company has expanded its senior management team with the hiring of Jens Oliver Funk, M.D. as Chief Scientific Officer (C
'/>"/>

SOURCE Principia Biopharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
2. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
3. PDL BioPharma Completes Regular Quarterly Dividend Payment
4. Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
5. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
6. PDL BioPharma to Present at Upcoming Investor Conferences
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
9. BioWorld Launches Enhanced Biopharma News Site with Data, Analysis
10. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
11. New Stroke Drug from ZZ Biotech Produced by Laureate Biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... Republican Whip,Roy Blunt (Mo.) issued the following statement today ... the State,Children,s Health Insurance Program (SCHIP) to children from ... "Today,s vote brings to a close what,s been a ... their energy to scoring,political points, and none of it ...
... Inc.,(Nasdaq: OMCL ), a leading provider of system ... third quarter ended September,30, 2007. GAAP results: Revenues ... $3.3 million or 6.4% from second quarter 2007 revenue ... the third quarter of 2006. Third quarter 2007 ...
... the cystic fibrosis chain uncover potential therapeutics , ... in the CFTR gene. Each mutation has number of effects ... vitro by Vojo Deretic and colleagues at the University of ... the mechanisms by which one of these changes impacts both ...
... a variety of symptoms, survey found , THURSDAY, Oct. 18 ... reflux, the less typical symptoms of gastroesophageal reflux disease (GERD) ... and chest pain -- can cause people significant sleep problems, ... 701 GERD patients found that sleep impairment was much more ...
... Damon,s Grill, as part of a,three- prong strategy ... trans fats from its menu nationwide. Earlier this ... States and Great Britain, became one of the first,casual ... Damon,s also this year launched its "Lighter Side of ...
... WASHINGTON, Oct. 18 - The nation,s mental,health system ... the U.S. Senate yesterday to provide new resources ... (D-RI) and Gordon H. Smith (R-OR) introduced S.,2182, ... The National Council for Community Behavioral Healthcare, which,championed ...
Cached Medicine News:Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 2Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 3Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 4Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 5Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 6Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 7Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 8Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 9Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 10Health News:Omnicell Reports Strong Q3 Revenue and Profit Growth 11Health News:JCI table of contents: Oct. 18, 2007 2Health News:JCI table of contents: Oct. 18, 2007 3Health News:JCI table of contents: Oct. 18, 2007 4Health News:JCI table of contents: Oct. 18, 2007 5Health News:JCI table of contents: Oct. 18, 2007 6Health News:JCI table of contents: Oct. 18, 2007 7Health News:JCI table of contents: Oct. 18, 2007 8Health News:JCI table of contents: Oct. 18, 2007 9Health News:Damon's Grill Completes Move to Trans Fat-Free Menu 2Health News:New Legislation Seeks to Improve Access to Community Mental Healthcare 2Health News:New Legislation Seeks to Improve Access to Community Mental Healthcare 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: